Torrent Pharmaceuticals has issued commercial papers worth Rs.300 crore, on May 25,2018.
The board of directors of the company are scheduled to meet on May 30,2018, to consider and approve the audited financial results for the year ended March 31,2018. Further, it will also consider the recommendation of final dividend for the year ended March 31, 2018.
